
“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
U.S. to deliver F-16 fighters to Egypt despite recent upheaval
Welcome, baseball fan. Go directly to jail.
Ex-Goldman Sachs director Rajat Gupta fined $13.9 million for insider trading
Gun sales hit new record, ammo boom to follow
How German fears of underwriting Russian oligarchs pushed Cyprus to crisis
Jewellers open Gulf shops to serve 50-60% rise in India gold sales
Mexican pot farmers give up, switch to supplying heroin to pill addicts
Once Again, Police Who Shot at Innocents Will Get Their Guns Back
U.S. Army investigates sexual assault prevention officer for sex abuse
San Mateo County deputy accused of child sex abuse
Theresa May government to create 'new internet' to control what is said online
What Putin Has to Say to Americans About Syria
Obama visits family of slain TSA officer
With 'Charity' For All
Glenn Greenwald's partner detained at Heathrow airport for nine hours